NUZ 5.26% 20.0¢ neurizon therapeutics limited

PAA 2022 , Human Trials , Covid , MND , Oncology , HVTL-1, K9 Phase III, page-966

  1. 2,642 Posts.
    lightbulb Created with Sketch. 1520
    No argument with this generally Peet however in this case it is the org supporting MND behind and indeed funding this trial plus there are very few available SOC options open to sufferers so not entirely sure awareness is an issue. More concerning would be that the candidates need to submit to what appears to be pretty stringent conditions and given there are only around 2000 potential candidates to begin with the pool is pretty small. Lets hope they can move ahead with a little more success than appears to have been the case with the dog cancer trials.
 
watchlist Created with Sketch. Add NUZ (ASX) to my watchlist
(20min delay)
Last
20.0¢
Change
0.010(5.26%)
Mkt cap ! $98.34M
Open High Low Value Volume
20.0¢ 20.5¢ 19.5¢ $86.20K 429.7K

Buyers (Bids)

No. Vol. Price($)
3 67508 19.5¢
 

Sellers (Offers)

Price($) Vol. No.
20.0¢ 36444 3
View Market Depth
Last trade - 16.10pm 15/11/2024 (20 minute delay) ?
NUZ (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.